Watch muscle with GLP‑1s
Coverage cautions that weight loss driven by GLP‑1 medications can come with muscle loss, so keeping protein intake high and prioritizing resistance training matters for long-term strength. (voiceofalexandria.com) The practical takeaway is simple: if you’re losing weight on medication, plan a strength program and protein strategy to avoid trading fat for functional muscle. (voiceofalexandria.com)
Glucagon-like peptide-1 drugs work by making food leave the stomach more slowly and by dialing down hunger signals, so people often eat far fewer calories without white-knuckling a diet. Semaglutide and tirzepatide turned that biology into average weight losses of about 15% in STEP 1 and up to about 21% in SURMOUNT-1. (nejm.org) (onlinelibrary.wiley.com) The catch is that the bathroom scale cannot tell you what left the body. Weight loss is usually a mix of fat mass and lean mass, and lean mass includes muscle, organs, and body water rather than fat alone. (mayoclinic.com) (nature.com) That is why doctors keep talking about body composition, which is the body’s split between fat and everything else. In a dual-energy X-ray absorptiometry substudy from STEP 1, semaglutide reduced total fat mass and also reduced lean body mass over 68 weeks. (academic.oup.com) (cci-cic.org) Tirzepatide showed the same pattern in a SURMOUNT-1 body-composition substudy. Over 72 weeks, people lost both fat mass and lean mass, even though fat made up the larger share of the loss. (onlinelibrary.wiley.com) (pubmedcentral.nih.gov) The rough rule from reviews and clinical commentary is that about one-quarter to two-fifths of weight lost on these drugs can come from lean mass. That range sounds alarming, but it is not unique to these medicines, because fast weight loss from dieting or bariatric surgery also strips away some lean tissue. (mayoclinic.com) (nature.com) Muscle still gets special attention because muscle is the body’s engine for movement and a major site for glucose disposal. Losing too much of it can leave people weaker, lower their resting energy use, and make weight regain harder to manage later. (nature.com) (jamanetwork.com) The simplest reason muscle slips during glucagon-like peptide-1 treatment is that appetite falls faster than nutrition planning improves. If someone suddenly eats much less and does no resistance exercise, the body has less protein coming in and less reason to keep expensive muscle tissue around. (jamanetwork.com) (health.harvard.edu) Resistance training is the signal that tells the body muscle is still needed. Coaches and clinicians commonly recommend lifting or other resistance work about three to five days a week, covering major muscle groups and gradually increasing the challenge over time. (msn.com) (health.harvard.edu) Protein is the raw material that lets that signal turn into actual repair. JAMA Internal Medicine advises many people on these drugs to start meals with 20 to 30 grams of protein and to aim for roughly 1.0 to 1.5 grams per kilogram of body weight per day if they are moderately active. (jamanetwork.com) The people who need the closest watch are older adults, people already losing strength, and anyone dropping weight very quickly. In those groups, a smaller reserve of muscle can turn into falls, frailty, or trouble doing ordinary tasks like climbing stairs or carrying groceries. (nature.com) (mayoclinic.com) So the new rule around these drugs is not just “Did the scale go down.” It is “Did fat go down while strength stayed up,” which means pairing the prescription with a protein plan, a lifting plan, and some way to track body composition or strength over time. (nature.com) (jamanetwork.com)
